Fortune of Temporary Ileostomies in Patients After Rectal Cancer Surgery
NCT ID: NCT02532478
Last Updated: 2015-08-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
160 participants
OBSERVATIONAL
2007-02-28
2014-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility Bowel Dysfunction Program After Low Anterior Resection
NCT04733794
Early Reversal of Defunctioning Stoma Trial
NCT00640913
PReventive cOlostomy vs Ileostomy in Low anTErior reCTal Resection
NCT04357171
Early Closure of Protective Ileostomy in Rectal Cancer Patients
NCT02997267
Transanal Reinforcement of Low Rectal Anastomosis in Rectal Cancer Surgery
NCT02279771
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The risk factors for stoma reversal failure have been rarely studied, which is probably one of the worst scenarios for a case who has a sphincter preserving procedure for a rectal cancer and is expecting to have regular bowel movements through a functional anus. Several studies have analyzed this particular issue and some have shown that up to 30% of 'temporary' stomas have never been closed. However these data have been criticized to be heterogeneous, since they have included patients with benign and malignant diseases, cases underwent elective or emergent anterior or low anterior resections or restorative proctocolectomy; and those with a colostomy or ileostomy, even an end stoma in some subjects. In addition, some studies have underlined some risk factors for the failure of stoma reversal, but they also have similar limitations as mentioned above. Finally, survival -to the best of investigators' knowledge- has never been separately studied in patients who cannot receive a stoma reversal procedure. Thus, current study aims to present a single-surgeon experience regarding the rate of diverting ileostomy takedown, the factors adversely affecting stoma reversal rate in patients underwent laparoscopic low anterior resection for rectal cancer, and accordingly to expose the fortune of these cases.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stoma reversed
Patients whose ileostomy have been closed after laparoscopic low anterior resection
No interventions assigned to this group
Stoma not-reversed
Patients whose ileostomy have not been closed due to some problems
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* those presenting with insitu cancer or dysplasia without an invasive cancer,
* those with cancers other than adenocarcinomas,
* those received a restorative proctocolectomy,
* those necessitated diversion for an irresectable tumor,
* those received a diverting/end colostomy or end ileostomy,
* Patients who had a recurrent disease and/or unresectable metastasis after the creation of stoma
* those received a temporary stoma during the last 12 months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr. Lutfi Kirdar Kartal Training and Research Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nuri Okkabaz
MD
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DrLutfi
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.